PEPCLUB

.me
Peptide Intelligence
Skin & Hair HealthRegeneration & RecoveryAnti-AgingArticlePremium

AHK-Cu

100mg Vial
2 September 2026Updated 2 September 2026
This is Premium content Premium

Create a free account, then upgrade to Premium or Lifetime to unlock the full research article, mechanism of action, results timeline, dosing protocol, and dose calculator for AHK-Cu.

Full range of benefits for AHK-Cu

Supports collagen and extracellular matrix synthesis

Promotes fibroblast proliferation and migration

Enhances wound healing and re-epithelialization

Modulates inflammation and matrix metalloproteinase activity

Exhibits antioxidant and free-radical scavenging effects

Stimulates angiogenesis to support tissue repair

May support hair follicle health and growth signaling

Demonstrates antimicrobial activity against skin microbes in vitro

May improve skin firmness and elasticity via ECM remodeling

This peptide's combination-safety and interaction data below always stays visible, regardless of membership.

Warning

Important information. The data compiled from scientific literature is provided for educational purposes. Dosage ranges reflect what is reported in studies and do not constitute a recommendation, prescription, or usage guidance. Health decisions should always be made with a qualified professional.

1 Published Studies

Scientific literature related to AHK-Cu and its potential applications.

Abstract analysed

The effect of tripeptide-copper complex on human hair growth in vitro.

In ex vivo human hair follicles and cultured human dermal papilla cells, AHK-Cu (10^-12 to 10^-9 M) stimulated follicle elongation and DPC proliferation and altered apoptosis-related proteins (increased Bcl-2/Bax, decreased cleaved caspase-3 and PARP), though a direct apoptosis assay showed a non-significant reduction in apoptotic cells; results are preclinical and limited by incomplete reporting in the abstract.

Confirmatory studies with reported sample sizes, replicates, and statistical analyses on human follicles and DPCs.Mechanistic studies linking molecular anti-apoptotic changes to functional outcomes in follicles.In vivo studies (animal models) and ultimately controlled human clinical trials to assess efficacy and safety.+2 more
Relevance
100%
Source
Europe PMC, PubMed
DOI: 10.1007/bf02978833
Published
2007